Pay in 4 interest-free payments of $6.43 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
You can absolutely express a preference
If left out for 46 hours, bioactivity is reduced by 7080%, rendering the solution largely ineffective for research purposes
Any unexpected reaction is reported through the clinics adverse-event protocol and triggers a documented response, not a generic chat reply
(Note: A similarly named but unrelated Vitals RX did receive an FDA warning letter in September 2025, but it is not the same pharmacy.) Additionally, Belle received an FDA warning letter in February of 2026 and was cited for misbranding after putting Belle labels on compounded GLP-1s
Aliquoting for Long-Term Studies Dividing reconstituted peptide into smaller portions extends usability
Provider credentialing with new payers is available at $99 per insurance payer
US$ 25.59
US$ 28.67
US$ 26.24
US$ 20.14
US$ 27.31
US$ 29.57
